Genetic biomarker to predict and monitor transplant rejection

Hematopoietic stem cell transplantation has recently become an important mainstay in oncology particularly for the treatment of lymphoproliferative disorders and leukemia.

http://www.innovations-report.com/html/reports/technology_offerings/genetic_biomarker_predict_monitor_transplant_208549.html